Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 526301 | NSE Symbol : | ISIN : INE047C01019 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
23-Jan-2025	30-Jan-2025	Quarterly Results	MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 inter alia to consider and approve the unaudited financial results (standalone & consolidated) of the Company for the quarter and nine months ended December 31 2024; and other corporate matters. Unaudited Financial Results along with limited review report. (As per BSE Announcement Dated on 30/01/2025)
19-Oct-2024	29-Oct-2024	Quarterly Results	MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve the standalone and consolidated unaudited financial results of the Company for the second quarter and half year ended September 30 2024; and Other corporate matters As per the attachment (As Per BSE Announcement dated on 29.10.2024)
23-Jul-2024	30-Jul-2024	Quarterly Results	MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2024 inter alia to consider and approve the unaudited financial results (Standalone and Consolidated) for the first quarter ended 30th June 2024 As per attachment Appointment of Internal Auditor and Secretarial Auditor (As Per BSE Announcement dated on 30.07.2024)
26-Jun-2024	26-Jun-2024	Scheme of Amalgamation	As per attachment
19-Apr-2024	26-Apr-2024	Quarterly Results	MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2024 inter alia to consider and approve Audited Financial Results for the quarter and year ended 31st March 2024 and other business matters MEDINOVA DIAGNOSTIC SERVICES LIMITED has informed BSE about Board Meeting to be held on 26 Apr 2024 to consider financial statements for the period ended March 2024. Financial results. (As Per BSE Announcement Dated on 21.04.2024) As per attachment (As Per BSE Announcement Dated on 26.04.2024)
23-Jan-2024	31-Jan-2024	Quarterly Results	MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve 1. The un-audited financial results (standalone & consolidated) of the Company for the third quarter and nine months ended December 31 2023; and 2. Other Corporate Matters As per attachment (As Per BSE Announcement Dated on: 31/01/2024)
18-Oct-2023	02-Nov-2023	Quarterly Results	MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30 September 2023 As per attachment As per attachment (As Per BSE Announcement Dated on 02/11/2023)
18-Jul-2023	28-Jul-2023	Quarterly Results	MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2023 inter alia to consider and approve We hereby informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2023 inter alia to consider and approve the Unaudited Financial Results (both Consolidated and Standalone) of the Company for the first quarter ended June 30 2023 and other corporate matters. As per attachment As per attachment (As Per BSE Announcement Dated on 28.07.2023)
09-May-2023	17-May-2023	Accounts	MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and disclosure Requirements) Regulations 2015 (Listing Regulations) we hereby inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday May 17 2023 inter alia to consider and approve: 1. The audited financial results (standalone & consolidated) of the Company for the fourth quarter and financial year ended March 31 2023; and 2. Other Corporate Matters Further this is to inform you that pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations 2015 and in accordance with the Companys Code of Conduct the trading window for dealing in the securities of the Company will remain closed from Saturday 1st April 2023 till Friday 19th May 2023 (both days inclusive) for designated persons. The designated persons of the Company have been informed of the same. Kindly take the information on record. As per attachment (As Per BSE Announcement Dated on 17.05.2023)
19-Jan-2023	01-Feb-2023	Quarterly Results	MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2023 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we hereby inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday February 01 2023 inter alia to consider and approve Un-audited standalone and consolidated financial results of the Company for the third quarter and nine months ended December 31 2022. As per attachment (As per BSE Announcement Dated on 01/02/2023)
03-Jan-2023	02-Jan-2023	Change in Registered Address	In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) 2015, We wish to inform you that Board of Directors of the Company vide Circular Resolution passed on 02 January 2023 have approved the Shifting of Registered office of the Company from H. No. 7-1-58/A/FF/8, 1st Floor, Office Flat / Unit No. 8, Amrutha Business Complex, Ameerpet, Hyderabad - 500016, Telangana, India to H. No. 7-1-58, Unit No. 1/Flat No. 301, 3rd Floor, Amrutha Business Complex, Ameerpet, Hyderabad - 500016, Telangana, India, within the same premises and within in the local limits of City with effect from 02 January 2023 due to the administrative convenience.
19-Oct-2022	02-Nov-2022	Quarterly Results	MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2022 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we hereby inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday November 02 2022 inter alia to consider and approve Un-audited standalone and consolidated financial results of the Company for the second quarter and half year ended September 30 2022. Kindly take the information on record. We hereby inform you that, the Board of Directors in their meeting held today i.e. on Wednesday November 02, 2022 has inter-alia considered and approved: 1. The Un-audited Standalone and Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2022. The aforesaid financial results together with the Limited review reports issued by M/s. M. Anandam & Co., Chartered Accountants, Statutory Auditors of the Company are enclosed. The Meeting commenced at 02:30 p.m. and concluded at 03:15 p.m. Kindly take the same on record. (As Per BSE Announcement Dated on 02/11/2022)
15-Jul-2022	27-Jul-2022	Quarterly Results	MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2022 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we hereby inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday July 27 2022 inter alia to consider and approve Un-audited standalone and consolidated financial results of the Company for the first quarter ended June 30 2022. Kindly take the information on record. We hereby inform you that, the Board of Directors in their meeting held today i.e. on Wednesday July 27, 2022 has inter-alia considered and approved: 1. The Un-audited Standalone and Consolidated Financial Results of the Company for the first quarter ended June 30, 2022. The aforesaid financial results together with the Limited review reports issued by M/s. M. Anandam & Co., Chartered Accountants, Statutory Auditors of the Company are enclosed. The Meeting commenced at 02.30 p.m. and concluded at 03.20 p.m. Kindly take the same on record. We hereby inform you that, the Board of Directors in their meeting held today i.e. on Wednesday July 27, 2022 has inter-alia considered and approved: 1. The Un-audited Standalone and Consolidated Financial Results of the Company for the first quarter ended June 30, 2022. The aforesaid financial results together with the Limited review reports issued by M/s. M. Anandam & Co., Chartered Accountants, Statutory Auditors of the Company are enclosed. The Meeting commenced at 02.30 p.m. and concluded at 03.20 p.m. Kindly take the same on record. (As Per BSE Announcement Dated on 27.07.2022)
09-May-2022	17-May-2022	Accounts	Audited Results We hereby inform you that, the Board of Directors in their meeting held today i.e. on Tuesday May 17, 2022 has inter-alia considered and approved: 1. The Audited Standalone and Consolidated Financial Results of the Company for the financial year ended March 31, 2022. The aforesaid financial results together with the Audit reports issued by M/s. M. Anandam & Co., Chartered Accountants, Statutory Auditors of the Company are enclosed herewith as Annexure A.we hereby confirm and declare that our Statutory Auditors M/s. M. Anandam & Co., issued the Auditor's Report with 'unmodified opinion' on the Audited Standalone and Consolidated Financial Results for the financial year ended March 31, 2022. 2. Appointment of Ms. Anusha Kanumuru, as Company Secretary & Compliance Officer of the Company. The brief details of the appointee are enclosed herewith as Annexure B. The Meeting commenced at 12.00 p.m. and concluded at 2.45 p.m. We hereby inform you that, the Board of Directors in their meeting held today i.e. on Tuesday May 17, 2022 has inter-alia considered and approved: 1. The Audited Standalone and Consolidated Financial Results of the Company for the financial year ended March 31, 2022. The aforesaid financial results together with the Audit reports issued by M/s. M. Anandam & Co., Chartered Accountants, Statutory Auditors of the Company are enclosed herewith as Annexure A. Pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm and declare that our Statutory Auditors M/s. M. Anandam & Co., issued the Auditor's Report with 'unmodified opinion' on the Audited Standalone and Consolidated Financial Results for the financial year ended March 31, 2022. 2.Appointment of Ms. Anusha Kanumuru, as Company Secretary & Compliance Officer of the Company. The brief details of the appointee are enclosed herewith as Annexure B. (As Per BSE Announcement Dated on 17.05.2022)
17-Jan-2022	28-Jan-2022	Quarterly Results	MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2022 inter alia to consider and approve In compliance with Regulation 29 of the SEBI (LODR) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday the 28th January 2022 at the Registered Office of the Company for considering and approving among others the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the Third Quarter and Nine Months period ended 31st December 2021. In compliance with Regulation 33 & 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the enclosed Standalone and Consolidated Un-Audited Financial Results for the quarter and nine months period ended 31st December, 2021 which have been reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on January 28, 2022 and also the Limited Review Report furnished by the Statutory Auditors of the Company. We wish to inform you that, pursuant to Regulation 30 the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at its Meeting held on January 28, 2022 has appointed Mr. Madhava Reddy Beeravelli as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the Company w.e.f. January 28, 2022. The Details required under Regulation 30 the Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9th September, 2015 is given in the enclosed Annexure. This is for your information and record. (As Per BSE Announcement dated on 28.01.2022) Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are enclosing herewith newspaper cuttings of Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended 31st December, 2021 published in Nava Telangana (Telugu newspaper) and Financial Express (English newspaper). (As per BSE Announcement Dated on 29/01/2022)

1 2

LOGIN HERE

Medinova Diagnostic Services Ltd

Board Meeting